EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
0,00%
(0,00) 1K
2,38 US$
arrow_downward
-0,95% (-0,023)bedtimeYopilgandan keyin
Savdolar yopilgan: 26-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,39 US$
Yuqori
2,44 US$
Past
2,36 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,88 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,39 US$
Yuqori
2,44 US$
Past
2,36 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,88 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Motley Fool
·
7 daqiqa oldin
Warren Buffett Says Buy an S&P 500 Index Fund. Here's What $500 a Month Is Worth in 20 Years at 3 Different Return Rates.
BigGo Finance
·
14 daqiqa oldin
BNB Standard Rings Nasdaq Bell as Largest Corporate BNB Holder, With Validator Plan on Deck
The Globe and Mail
·
32 daqiqa oldin
Is a Stock Market Crash Coming? What History Says a $10,000 Investment in an S&P 500 ETF Could Be Worth at the End of 2027.
Bloomberg.com
·
9 soat oldin
What to Know About the Anthropic IPO
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida